FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to note that Portage Biotech Inc. ( Portage ) has today announced its 2021 research and development goals , including advancing three of its pipeline assets through clinical trials during the upcoming year. Portage also announced that it has received approval from the NASDAQ Capital Market ( NASDAQ ) to list its common shares on the NASDAQ exchange, and expects to commence trading on 25 February 2021 under the symbol PRTG . FastForward has a 0.56% interest in the issued stock of Portage. Ed McDermott, CEO of FastForward Innovations, commented:
Agronomics, a leading listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat, is pleased to announce portfolio company New Age Meats (trading name for Simply Foods, Inc) has raised a further US$ 2 million via convertible debt. In July 2019, Agronomics completed a subscription of US$ 699,999.34 for 885,739 Series Seed Preferred Shares. Agronomics currently holds approximately 7.0% in New Age Meats on a fully diluted basis. This further raise does not result in a change to the carrying or implied value of Agronomics holding in New Age Meats. The full announcement is set out below with no material changes or adjustments:
05 FEBRUARY 2021 Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announced the pricing of its upsized initial public offering in the United States of 9,935,896 American Depositary Shares ( ADSs ) representing 9,935,896 ordinary shares at an initial public offering price of $26.00 per ADS, for total gross proceeds of approximately $258.3 million. All ADSs sold in the offering were offered by Immunocore. The ADSs are expected to begin trading on The Nasdaq Global Select Market on February 5, 2021 under the ticker symbol IMCR. In addition, Immunocore has granted the underwriters a 30-day option to purchase up to an additional 1,490,384 ADSs at the initial public offering price, less underwriting discounts and commissions. The offering
บอร์ดก ล ต มีมติให้ Bitkub ระงับเปิดรับลูกค้าใหม่และแก้ไขระบบงานเพิ่ม ryt9.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ryt9.com Daily Mail and Mail on Sunday newspapers.
This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as expect, look forward to, anticipate intend, plan, believe, seek, estimate, will, project or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, on social media, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Tekcapital s management. Please note that these are subject to a number of risks, uncertainties and factors, including, but no